QUADRIGA BIOSCIENCES
Quadriga BioSciences technology is based on the discovery that many aggressive forms of cancer cells over-express certain unique amino acid transporters on their cell surfaces for the intake of nutrients to support rapid tumor growth and proliferation. Exploiting this biology, Quadriga is developing novel targeted molecules against cancer cells that over-express these transporters.
QUADRIGA BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.quadrigabiosciences.com
Total Employee:
1+
Status:
Active
Contact:
+ 1 650 917 9098
Similar Organizations
AGI Biopharmaceuticals
AGI Biopharmaceuticals offers a patented melanoma vaccine with future multi-cancer applications.
BiPar Sciences
BiPar Sciences is a pharmacological company developing PARP inhibitors as cancer therapies.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Khepri Pharmaceuticals
Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics.
KYAN Therapeutics
KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
Mycota Biosciences Inc
Mycota Biosciences is a company that researches and develop proprietary method for identifying genes
NewEast Biosciences
NewEast Biosciences is a laboratory dedicated to bio-assays of various biological cultures.
Nirova BioSense
Nirova BioSense is a health-care clinic that specializes in cancer therapy.
Translational Bioscience
Translating Bioscience is a pharmaceutical company that gives contract research services to biotech and pharma firms to grow therapeutics.
Vespina Lifesciences
Vespina Lifesciences plans to develop a potential compound with the potential to treat certain types of inflammatory diseases.
Official Site Inspections
http://www.quadrigabiosciences.com Semrush global rank: 5.98 M Semrush visits lastest month: 1.37 K
- Host name: 35.86.215.35.bc.googleusercontent.com
- IP address: 35.215.86.35
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Quadriga BioSciences"
Quadriga BioSciences, Inc.
Wolf-Nicolas Fischer, Ph.D., is a Co-Founder of Quadriga BioSciences and currently serves as …See details»
Quadriga BioSciences, Inc. - Advancing Novel …
Quadriga is developing QBS72S, a novel, first-in-class chemotherapeutic agent that is transported by L-type Amino Acid Transporter 1 (LAT1) across the blood brain barrier and into rapidly growing cancer cells.See details»
Quadriga BioSciences - Crunchbase Company Profile & Funding
Contact Email info@quadrigabiosciences.com Phone Number + 1 650 917 9098 Quadriga …See details»
Quadriga BioSciences, Inc. | LinkedIn
Quadriga BioSciences, Inc. is a privately-held pharmaceutical company developing proprietary …See details»
Quadriga BioSciences - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Quadriga …See details»
QUADRIGA BIOSCIENCES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for QUADRIGA …See details»
Quadriga BioSciences - Overview, News & Similar companies
Quadriga BioSciences contact info: Phone number: (650) 917-9098 Website: …See details»
Quadriga BioSciences Company Profile | Management and
Company Name. Quadriga BioSciences. Main Industry. Research & Development, Business …See details»
Quadriga BioSciences, Inc.
Quadriga is actively seeking partners dedicated to advancing the clinical development of …See details»
Quadriga BioSciences, Inc. - PubChem Data Source
May 18, 2021 Quadriga BioSciences, Inc. is a privately-held biopharmaceutical company …See details»
Quadriga BioSciences Announces Dosing of First Subject in Phase …
Feb 14, 2023 For more information, please visit www.quadrigabiosciences.com. Contact …See details»
Quadriga BioSciences Announces Completion of Enrollment in …
Info@quadrigabiosciences.com +1 (650) 917 9098 . Media Inquiries . David Melamed, Ph.D. …See details»
Phase 1b/2a Trial of QBS-72S for the Treatment of Newly …
Email: gordon.ringold@quadrigabiosciences.com. Business Contact. Name: GORDON …See details»
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted ...
Jul 23, 2020 www.quadrigabiosciences.com. About NBQ. NBQ is an innovative, clinical-stage …See details»
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted ...
LOS ALTOS, Calif., July 23, 2020 /PRNewswire/ -- Quadriga BioSciences, a leader in the field …See details»
Quadriga BioSciences, Inc. - News & Media
Oct 10, 2017 April 11, 2023 Quadriga BioSciences Announces Dosing of First Subject in …See details»
Gordon Ringold - Quadriga Biosciences - LinkedIn
Professor of Pharmacology, Stanford 1978-1987<br>VP Syntex Research… · Experience: …See details»
Quadriga BioSciences, Inc. (Quadriga BioSciences, Inc.) - 药物管线_ …
了解Quadriga BioSciences, Inc. (Quadriga BioSciences, Inc.)公司的药物管线，治疗领域，技术 …See details»
Quadriga BioSciences Announces Dosing of First Subject in Phase …
Www.quadrigabiosciences.com. Contact Information . General Inquiries . …See details»
Quadriga BioSciences, Inc. - Our Science
Many aggressive solid tumors and hematologic malignancies overexpress the LAT1 transporter …See details»